Eden Research (EDEN) Share Price, News & Analysis

Company Overview

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries. Eden's products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides. Eden has two products currently on the market: Based on plant-derived active ingredients, Mevalone ® is a foliar biofungicide which initially targets a key disease affecting grapes and other high-value fruit and vegetable crops. It is a useful tool in crop defence programmes and is aligned with the requirements of integrated pest management programmes. It is approved for sale in a number of key countries whilst Eden and its partners pursue regulatory clearance in new territories thereby growing Eden's addressable market globally. Cedroz ™ is a bionematicide that targets free living nematodes which are parasitic worms that affect a wide range of high-value fruit and vegetable crops globally. Cedroz is registered for sale on two continents and Eden's commercial collaborator, Eastman Chemical, is pursuing registration and commercialisation of this important new product in numerous countries globally. Eden's Sustaine ® encapsulation technology is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic compounds to enhance their performance and ease-of-use. Sustaine microcapsules are naturally-derived, plastic-free, biodegradable micro-spheres derived from yeast. It is one of the only viable, proven and immediately registerable solutions to the microplastics problem in formulations requiring encapsulation. Eden was admitted to trading on AIM on 11 May 2012 and trades under the symbol EDEN. It was awarded the London Stock Exchange Green Economy Mark in January 2021, which recognises London-listed companies that derive over 50% of their total annual revenue from products and services that contribute to the global green economy. Eden derives 100% of its total annual revenues from sustainable products and services. For more information about Eden, please visit: www.edenresearch.com .

Key Stats

• Today's Range: 2.88 to 2.90
• 50-Day Range: 2.80 to 4.12
• 52-Week Range: 2.75 to 5.22
• Volume: 20,000 shs
• Average Volume: 763,227 shs
• Market Capitalization: £15.36 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EDEN Stock Analysis - Frequently Asked Questions

How have EDEN shares performed this year?

Eden Research's stock was trading at GBX 3.90 at the start of the year. Since then, EDEN shares have decreased by 23.4% and is now trading at GBX 2.99.
View the best growth stocks for 2025 here.

How were Eden Research's earnings last quarter?

Eden Research plc (LON:EDEN) announced its quarterly earnings results on Tuesday, September, 29th. The company reported ($0.40) earnings per share for the quarter. Eden Research had a negative net margin of 38.70% and a negative trailing twelve-month return on equity of 11.63%.

How do I buy shares of Eden Research?

Shares of EDEN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Eden Research own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Eden Research investors own include Kromek Group (KMK), Primary Health Properties (PHP), National Grid (NG.L), Cabot Energy (CAB), EPE Special Opportunities (ESO), Marston's (MARS) and Mothercare (MTC).

Company Calendar

• Last Earnings: 9/29/2020
• Today: 3/26/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Basic Materials
• Industry: Agricultural Inputs
• Sub-Industry: N/A
• Current Symbol: LON:EDEN
• CIK: N/A
• Web: www.edenresearch.com
• Phone: +44-1285-359555
• Fax: N/A
• Employees: 19
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.29)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £-1,522,582.96
• Net Margins: -38.70%
• Pretax Margin: N/A
• Return on Equity: -11.63%
• Return on Assets: -11.29%

Debt

• Debt-to-Equity Ratio: 1.26
• Current Ratio: 3.80
• Quick Ratio: 2.42

Sales & Book Value

• Annual Sales: £3.93 million
• Price / Sales: 4.05
• Cash Flow: GBX 0.25 per share
• Price / Cash Flow: 11.90
• Book Value: GBX 2.38 per share
• Price / Book: 1.25

Miscellaneous

• Outstanding Shares: 533,353,000
• Free Float: N/A
• Market Cap: £15.94 million
• Optionable: Not Optionable
• Beta: 0.92